Stay updated on Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page
- Check2 days agoChange DetectedRecruitment is no longer looking for participants, indicating enrollment has ended. The record history now includes a new revision tag v3.6.0 and removes the previous tag v3.5.5.SummaryDifference0.4%

- Check9 days agoChange DetectedA new revision entry (v3.5.5) was added to the study's history, and the previous revision (v3.5.4) was removed, reflecting an administrative update to the record history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry labeled v3.5.4 has been added to the Record History, replacing the previous v3.5.3. This indicates an updated version of the study record.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision line, Revision: v3.5.3, appears in the Record History. It supersedes the previous Revision: v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedThe record history now includes a new revision entry (v3.5.2) and removes the previous revision (v3.5.0).SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the Record History.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes Switch from GLP-1 RA Clinical Trial page.